Andreas Zachariades

Dr. Andreas Zachariades

European University Cyprus, Nicosia, Lefkosía, Cyprus

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2017 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SZSavvas Zannetos
Savvas Zannetos
TZTheodora Zachariadou
Theodora Zachariadou
Andreas ZachariadesAndreas Zachariades
Andreas Zachariades
AGAndreas Georgiou
Andreas Georgiou
Michael A. TaliasMichael A. Talias
Michael A. Talias
Asthma is one of the main non-infectious diseases of the respiratory system with substantial economic burden worldwide. The objective of this study was to estimate the economic burden of adult asthma in Cyprus during 2015. A retrospective probabilistic prevalence-based cost of illness model was developed to calculate the economic burden of asthma including direct and indirect costs. The bottom-up approach (person-based data) was used for the calculation of direct costs while for the calculation of indirect costs the approach of human capital was employed. In addition, bootstrapped sensitivity analysis with 1000 bootstrap simulations was performed in order to calculate a 95% Confidence Interval (CI). Mean patient cost of asthma in Cyprus in 2015 was estimated at €579.64 (95% CI: €376.90–€813.68). Direct costs accounted for 82.08% of the overall expenses, €475.75 per patient (95% CI: €296.94–€697.69). Indirect costs of €103.89 (95% CI: €49.59–€181.46) accounted for 17.92% of the overall expenses. This was the first study in Cyprus, which used bootstrapped prevalence-based cost of illness model to estimate the cost of asthma. This study confirms that asthma is an expensive disease for the society. In addition, it provides important information and analysis of the economic consequences of asthma to policy makers in order to strengthen surveillance of the disease as well as draft the national health policy accordingly.

20 March 2012 in COPD: Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Closed access
Andreas ZachariadesAndreas Zachariades
Andreas Zachariades
TZTheodora Zachariadou
Theodora Zachariadou
TATonia Adamide
Tonia Adamide
UAUrania Anagnostopoulou
Urania Anagnostopoulou
AGAndreas Georgiou
Andreas Georgiou
KGKonstantinos I Gourgoulianis
Konstantinos I Gourgoulianis
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Cyprus is largely unknown. The aim of the study was to estimate the prevalence of COPD in Cyprus through a spirometry population- based program and to identify certain disease characteristics in the Cypriot population.